ResMed CEO sells 4,993 shares after option exercise
Alpha Vantage · The Globe and Mail · · AI-summarised by FinFlash
ResMed's Chairman and CEO, Michael J. Farrell, recently exercised options for 4,993 common shares at Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.Understand the context